Loading...
Loading...
India's glibenclamide imports from UNITED STATES total $817 across 3 shipments from 1 foreign suppliers. CELL SIGNALING TECHNOLOGY leads with $817 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include COUNCIL OF SCIENTIEIC INDL RESEARCH. This corridor reflects India's pharmaceutical import demand for glibenclamide — a concentrated sourcing relationship with select suppliers from UNITED STATES.

CELL SIGNALING TECHNOLOGY is the leading Glibenclamide supplier from UNITED STATES to India, with import value of $817 across 3 shipments. The top 5 suppliers — CELL SIGNALING TECHNOLOGY — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CELL SIGNALING TECHNOLOGY | $817 | 3 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | COUNCIL OF SCIENTIEIC INDL RESEARCH | $293 | 1 | 35.8% |
| 2 | IMPERIAL LIFE SCIENCES PVT LTD | $276 | 1 | 33.8% |
| 3 | ZELLE BIOTECHNOLOGY PRIVATE LIMITED | $249 | 1 | 30.4% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Glibenclamide suppliers from UNITED STATES to India include CELL SIGNALING TECHNOLOGY. The leading supplier is CELL SIGNALING TECHNOLOGY with import value of $817 USD across 3 shipments. India imported Glibenclamide worth $817 USD from UNITED STATES in total across 3 shipments.
India imported Glibenclamide worth $817 USD from UNITED STATES across 3 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Glibenclamide sourced from UNITED STATES include COUNCIL OF SCIENTIEIC INDL RESEARCH, IMPERIAL LIFE SCIENCES PVT LTD, ZELLE BIOTECHNOLOGY PRIVATE LIMITED. The largest buyer is COUNCIL OF SCIENTIEIC INDL RESEARCH with $293 in imports across 1 shipments.
The total value of Glibenclamide imports from UNITED STATES to India is $817 USD, across 3 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3 Verified Shipments
1 suppliers, 3 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists